ViroPharma

3 results

The Health Products Regulatory Authority (HPRA), formerly the Irish Medicines Board, advised that ViroPharma SPRL recall several batches of the Buccolam Oromucosal Solution products from pharmacies.

Several batches of a drug used to treat convulsive seizures in children and adolescents have been recalled from pharmacies as a precautionary measure.(...)

 US stocks barely budged in thin trading after investors found little reason to add significant new positions with the Dow and the S&P 500 on a five-week winning streak. Photographer: Gino Domenico /Bloomberg

Better than forecast industrial data from China gave a boost to stocks on this side of the Atlantic while in the US the markets were becalmed as the b(...)

 Shire latched onto the rare disease drugs trend years before bigger rivals. Photographer: JB Reed/Bloomberg

London-listed Shire is buying ViroPharma for $4.2 billion its biggest deal yet to strengthen its portfolio of lucrative drugs to treat rare diseases, (...)